As per annexure enclosed
Awaiting price reaction for this filing.
Apollo Hospitals' Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2025 with a clean (unmodified) opinion from auditor Deloitte Haskins & Sells LLP. Standalone revenue grew to Rs. 8,202 crore (up ~13% YoY) and standalone PAT rose to Rs. 1,296 crore (up ~28% YoY); consolidated revenue reached Rs. 21,794 crore with PAT of Rs. 1,505 crore (up ~61% YoY). The Board recommended a final dividend of Rs. 10/share (200%) on top of the Rs. 9 interim dividend already paid, taking total FY25 dividend to Rs. 19/share (380%). It also approved the re-appointment of three Executive Directors (Preetha, Suneeta and Sangita Reddy) for 5 years, re-appointment of Independent Director Som Mittal, appointment of new Secretarial Auditors, and a Rs. 285 crore proposal to acquire a 200-bed hospital asset. Credit ratings were reaffirmed at AA+/Stable by both CRISIL and India Ratings.
Strong earnings growth, especially the ~61% jump in consolidated PAT, signals robust operating momentum and is positive for shareholders; the higher total dividend (Rs. 19 vs prior year's ~Rs 17.5 effective payout) reinforces income appeal, while the Rs. 285 crore acquisition points to continued capacity expansion.